Clinical Trial Update: A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Lot Consistency Trial) [Phase 4]

View source ↗

Summary

Phase 4 lot consistency trial of the recombinant hepatitis E vaccine (Escherichia coli) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis E

Drugs mentioned

• Recombinant Hepatitis E Vaccine (Escherichia Coli) (Hepatitis E vaccine (recombinant, E. coli expression))

Snippet

Sponsor: Xiamen Innovax Biotech Co., Ltd | Conditions: Hepatitis E | Phase 4 | Status: COMPLETED